Emerging Technologies for Food and Drug Safety.

William Slikker,Thalita Antony de Souza Lima,Davide Archella,Jarbas Barbosa de Silva Junior,Tara Barton-Maclaren,Li Bo,Danitza Buvinich,Qasim Chaudhry,Peiying Chuan,Hubert Deluyker,Gary Domselaar,Meiruze Freitas,Barry Hardy,Hans-Georg Eichler,Marta Hugas,Kenneth Lee,Chia-Ding Liao,Lit-Hsin Loo,Haruhiro Okuda,Orish Ebere Orisakwe,Anil Patri,Carl Sactitono,Leming Shi,Primal Silva,Frank Sistare,Shraddha Thakkar,Weida Tong,Mary Lou Valdez,Maurice Whelan,Anna Zhao-Wong
DOI: https://doi.org/10.1016/j.yrtph.2018.07.013
IF: 3.598
2018-01-01
Regulatory Toxicology and Pharmacology
Abstract:Emerging technologies are playing a major role in the generation of new approaches to assess the safety of both foods and drugs. However, the integration of emerging technologies in the regulatory decision-making process requires rigorous assessment and consensus amongst international partners and research communities. To that end, the Global Coalition for Regulatory Science Research (GCRSR) in partnership with the Brazilian Health Surveillance Agency (ANVISA) hosted the seventh Global Summit on Regulatory Science (GSRS17) in Brasilia, Brazil on September 18-20, 2017 to discuss the role of new approaches in regulatory science with a specific emphasis on applications in food and medical product safety. The global regulatory landscape concerning the application of new technologies was assessed in several countries worldwide. Challenges and issues were discussed in the context of developing an international consensus for objective criteria in the development, application and review of emerging technologies. The need for advanced approaches to allow for faster, less expensive and more predictive methodologies was elaborated. In addition, the strengths and weaknesses of each new approach was discussed. And finally, the need for standards and reproducible approaches was reviewed to enhance the application of the emerging technologies to improve food and drug safety. The overarching goal of GSRS17 was to provide a venue where regulators and researchers meet to develop collaborations addressing the most pressing scientific challenges and facilitate the adoption of novel technical innovations to advance the field of regulatory science.
What problem does this paper attempt to address?